2022
DOI: 10.34133/2022/9826426
|View full text |Cite
|
Sign up to set email alerts
|

Programming of Regulatory T Cells In Situ for Nerve Regeneration and Long-Term Patency of Vascular Grafts

Abstract: Rapid integration into the host tissue is critical for long-term patency after small diameter tissue engineering vascular grafts (sdTEVGs) transplantation. Neural recognition may be required for host integration and functionalization of the graft. However, immune rejection and inflammation hinder nerve regeneration of sdTEVGs. Here, a CRISPR/dCas9-nanocarrier was used for targeted programming of regulatory T cells (Treg cells) in situ to promote nerve regeneration of sdTEVGs by preventing excessive inflammatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 57 publications
0
4
0
Order By: Relevance
“…IL‐6, a prototypical inflammatory factor originating from macrophages and other immune cells, has been shown to be involved in nerve regeneration. [ 33 ] Thus, we applied IL‐6 staining to examine the differences among the various treatment groups. As depicted in Figure S26 (Supporting Information), the number of IL6‐positive cells at the injury site was notably greater than that in the normal group, and there was no significant difference in the reduction in inflammation in the GAC group.…”
Section: Resultsmentioning
confidence: 99%
“…IL‐6, a prototypical inflammatory factor originating from macrophages and other immune cells, has been shown to be involved in nerve regeneration. [ 33 ] Thus, we applied IL‐6 staining to examine the differences among the various treatment groups. As depicted in Figure S26 (Supporting Information), the number of IL6‐positive cells at the injury site was notably greater than that in the normal group, and there was no significant difference in the reduction in inflammation in the GAC group.…”
Section: Resultsmentioning
confidence: 99%
“…94 An innovative strategy employed a Treg-specific nanodelivery system to enhance Treg potency for controlling inflammation for small diameter tissue engineering vascular grafts (sdTEVGs) transplantation. 101 This approach directly increased TET2 expression within Tregs using dCas9-VP64 and sgRNA, resulting in potent control of inflammation in vivo. 101 Utilizing the CRISPRon system in combination with nanodelivery techniques could facilitate highly specific in vivo targeting of Treg cells, focusing on regions such as the FOXP3 TSDR.…”
Section: ■ Autoimmunity and Regulatory T Cellsmentioning
confidence: 99%
“…101 This approach directly increased TET2 expression within Tregs using dCas9-VP64 and sgRNA, resulting in potent control of inflammation in vivo. 101 Utilizing the CRISPRon system in combination with nanodelivery techniques could facilitate highly specific in vivo targeting of Treg cells, focusing on regions such as the FOXP3 TSDR.…”
Section: ■ Autoimmunity and Regulatory T Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 1 ] This system is pivotal in injured tissues, where incomplete Vascular Endothelial Growth Factor (VEGF) signaling may drive organ tissue aging and damage. [ 2 ] Conversely, elevating VEGF signaling can prevent age‐related capillary loss, improving perfusion and function in various injured tissues, ultimately extending lifespan. [ 3 ] In addition, Fu et al.…”
Section: Introductionmentioning
confidence: 99%